Streetbeat News

Stock Prices

ZJYL

Jin Medical International (NYSE:ZJYL) has seen a 16.84% increase in short interest since the last report, with 64 thousand shares sold short, representing 3.47% of its float. The short interest is below the peer group average of 8.78%. While an increase in short interest can indicate bearish sentiment, it does not necessarily predict a near-term price drop.

Portfolio Pulse from Benzinga Insights

January 22, 2024 | 1:00 pm

OGN

Organon (NYSE:OGN) has seen a 5.82% increase in short interest since its last report, with 19.12 million shares sold short, representing 8.54% of its float. It would take about 5 days to cover all short positions. While an increase in short interest can indicate bearish sentiment, it doesn't necessarily predict a price drop. Organon's short interest is higher than its peer group average of 3.56%.

Portfolio Pulse from Benzinga Insights

January 22, 2024 | 1:00 pm

SXTC

China SXT Pharmaceuticals (NYSE:SXTC) has seen a significant decrease in short interest, with a 67.38% drop since the last report. The current short interest stands at 6 thousand shares, or 1.52% of the float, with a short-covering time of approximately 1 day. This decline in short interest may indicate a more bullish sentiment among investors compared to the peer group average of 2.98% short interest as a percentage of float.

Portfolio Pulse from Benzinga Insights

January 22, 2024 | 1:00 pm

NOW

JMP Securities analyst Patrick Walravens has maintained a Market Outperform rating on ServiceNow (NYSE:NOW) and increased the price target from $665 to $825, indicating a positive outlook on the company's stock performance.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 1:00 pm

XMTR

Goldman Sachs analyst Bruno Montanari has reaffirmed a Buy rating on Xometry (NASDAQ:XMTR) and increased the price target from $29 to $46, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 12:56 pm

TRV

Goldman Sachs analyst Alex Scott has maintained a Sell rating on Travelers Companies (NYSE:TRV) but increased the price target from $166 to $186.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 12:53 pm

SPWR

Goldman Sachs analyst Brian Lee has reiterated a Sell rating on SunPower (NASDAQ:SPWR) and reduced the price target from $4 to $2.5.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 12:51 pm

META

TSLA

TWTR

TikTok founder Zhang Yiming expressed admiration for Elon Musk's ability to consistently undertake challenging and innovative projects. Musk responded positively to Yiming's comments. The praise comes amidst criticism Musk has faced over his Twitter acquisition, interactions with Mark Zuckerberg, and his desire to increase his stake in Tesla. Jim Cramer has suggested Tesla may be the first to fall from the 'Magnificent 7' stock group due to Musk's behavior.

Portfolio Pulse from Rounak Jain

January 22, 2024 | 12:47 pm

NS

SUN

Sunoco has agreed to acquire NuStar in an all-equity deal valued at approximately $7.3 billion, including assumed debt. NuStar unitholders will receive 0.400 Sunoco units per NuStar unit, a 24% premium based on the 30-day VWAP as of January 19, 2024. The boards of both companies have approved the transaction, expected to close in Q2 2024.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 12:47 pm

DNTH

Dianthus Therapeutics has entered into an agreement for a Private Investment in Public Equity (PIPE) financing deal, which is anticipated to generate $230 million in gross proceeds. The company will sell 14,500,500 shares of common stock at $12.00 each and pre-funded warrants for 4,666,332 shares at $11.999 each. The expected closing date for the PIPE financing is January 24, 2024.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 12:43 pm